Immune Evasion, Tumor

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Immune Evasion, Tumor trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT07432347

Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches

This is a national, observational, retrospective, cross-sectional, non-profit study focused on patients with HCC. The study aims to characterize the expression…

Italy270 participantsStarted 2026-01-01

Treatment: Collection of tumor tissue (Fresh or/and archival FFPE), blood samples

RecruitingNot Applicable

NCT07034339

Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution

The intricate interplay between systemic immunity and tumors profoundly influences not only the onset and progression of tumors but also serves as a crucial win…

China1,500 participantsStarted 2025-05-21

All recent trials (10 shown)

TerminatedNot Applicable

NCT03960021

Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin

Local percutaneous thermal ablation is frequently proposed in the management of metastatic diseases. Radiofrequency ablation (RFA) has demonstrated good results…

France20 participantsStarted 2019-03-04

Treatment: RFA interventions

CompletedNot Applicable

NCT06657755

Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients

This study aims to investigate the role of ENPP1 in bladder cancer (BC), specifically focusing on its impact on immune evasion, chemoresistance, and prognosis.…

China12 participantsStarted 2024-06-01

Treatment: Immunohistochemistry

Immune Evasion, Tumor

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches

Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution

All recent trials (10 shown)

Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin

Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches

Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution

All recent trials (10 shown)

Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin

Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients

Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer

Natural Killer Cell Immunotherapy in Combination With PARP-inhibition in Acute Myeloid Leukemia

Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary

NGS Combined With RNAseq on Tumor Immune Escape in NSCLC

Immunoevasive Tactics Employed by Myeloid Malignancy After Allogeneic Stem Cell Transplantation

Exercise, Prostate Cancer and Circulating Tumour Cells